N-(2-(6,7-Dichloro-9-(1-methyl-1H-pyrazol-3-yl)-1,3,4,5-tetrahydro-2H-pyrido[4,3-b]indol-2-yl)-2-oxoethyl)-2-(furan-2-yl)acetamide

ID: ALA5092170

PubChem CID: 166632113

Max Phase: Preclinical

Molecular Formula: C23H21Cl2N5O3

Molecular Weight: 486.36

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cn1ccc(-c2cc(Cl)c(Cl)c3[nH]c4c(c23)CN(C(=O)CNC(=O)Cc2ccco2)CC4)n1

Standard InChI:  InChI=1S/C23H21Cl2N5O3/c1-29-6-4-18(28-29)14-10-16(24)22(25)23-21(14)15-12-30(7-5-17(15)27-23)20(32)11-26-19(31)9-13-3-2-8-33-13/h2-4,6,8,10,27H,5,7,9,11-12H2,1H3,(H,26,31)

Standard InChI Key:  AJZDPINAQHQTPL-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 33 37  0  0  0  0  0  0  0  0999 V2000
   14.8195  -12.9595    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8183  -13.7831    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5305  -14.1921    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5287  -12.5465    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2414  -12.9559    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2462  -13.7786    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0304  -14.0270    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.0226  -12.6943    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.5105  -13.3560    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3215  -13.2664    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6509  -12.5160    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1672  -11.8543    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.3499  -11.9430    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1103  -14.1912    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   15.5315  -15.0134    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   15.5231  -11.7279    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1869  -11.2456    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.9321  -10.4650    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1107  -10.4675    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.8565  -11.2495    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.6242   -9.8037    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.4960  -11.1020    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3124  -11.0126    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0083  -10.4432    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.8000  -11.6755    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.6165  -11.5861    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.1000  -12.2490    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.9452  -10.8338    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   21.9164  -12.1596    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.4703  -12.7629    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.2194  -12.4269    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.1300  -11.6104    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.3257  -11.4445    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  9  1  0
  8  5  1  0
  8  9  2  0
  8 13  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
  2 14  1  0
  3 15  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  1  0
 20 16  2  0
  4 16  1  0
 19 21  1  0
 12 22  1  0
 22 23  1  0
 22 24  2  0
 23 25  1  0
 25 26  1  0
 26 27  1  0
 26 28  2  0
 27 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 33  1  0
 33 29  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5092170

    ---

Associated Targets(Human)

THP1-Dual (100 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CGAS Tchem Cyclic GMP-AMP synthase (693 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Cgas Cyclic GMP-AMP synthase (121 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 486.36Molecular Weight (Monoisotopic): 485.1021AlogP: 3.71#Rotatable Bonds: 5
Polar Surface Area: 96.16Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 12.03CX Basic pKa: 1.95CX LogP: 2.43CX LogD: 2.43
Aromatic Rings: 4Heavy Atoms: 33QED Weighted: 0.45Np Likeness Score: -1.74

References

1. Tan J, Wu B, Chen T, Fan C, Zhao J, Xiong C, Feng C, Xiao R, Ding C, Tang W, Zhang A..  (2021)  Synthesis and Pharmacological Evaluation of Tetrahydro-γ-carboline Derivatives as Potent Anti-inflammatory Agents Targeting Cyclic GMP-AMP Synthase.,  64  (11.0): [PMID:34044539] [10.1021/acs.jmedchem.1c00398]

Source